Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient

International Journal of Hematology

Volumn 88, Issue 3, 2008, Pages 336-340

  Shima, Takahiro ^a   Yoshimoto, Goichi ^a   Nonami, Atsushi ^a   Yoshida, Shuro ^a   Kamezaki, Kenjiro ^a   Iwasaki, Hiromi ^a   Takenaka, Katsuto ^a   Miyamoto, Toshihiro ^a   Harada, Naoki ^a   Teshima, Takanori ^a   Akashi, Koichi ^a   Nagafuji, Koji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; Parainfluenza virus; Pneumonia; Ribavirin

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; METHOTREXATE; METHYLPREDNISOLONE; OXYGEN; PREDNISOLONE; RIBAVIRIN; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; COUGHING; DISEASE EXACERBATION; DONOR; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HYPOXIA; INFORMED CONSENT; LEUKEMIA REMISSION; OXYGEN THERAPY; PARAINFLUENZA VIRUS; RECURRENT DISEASE; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; VIRUS PNEUMONIA; WHOLE BODY RADIATION;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; METHYLPREDNISOLONE; PARAINFLUENZA VIRUS 3, HUMAN; PNEUMONIA, VIRAL; RESPIROVIRUS INFECTIONS; RIBAVIRIN; TRANSPLANTATION, HOMOLOGOUS;

EID: 60049087121     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0148-6     Document Type: Article

References (29)

1. WG Nichols L Corey T Gooley C Davis M Boeckh 2001 Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome Blood 93 573 8 10.1182/blood.V98.3.573
2. RF Chemaly S Ghosh GP Bodey N Rohatgi A Safdar MJ Keating 2006 Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center Medicine 85 78 287 10.1097/01.md.0000232560.22098.4e
3. R Vainionpaa T Hyypia 1994 Biology of parainfluenza viruses Clin Microbiol Rev 7 265 75
4. H Laurichesse D Dedman JM Watson MC Zambon 1999 Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997 Eur J Epidemiol 15 475 84 10.1023/A:1007511018330
5. S Chakrabarti I Avivi S Mackinnon K Ward PD Kottaridis H Osman 2002 Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality Br J Haematol 119 1125 32 10.1046/j.1365-2141.2002.03992.x
6. SM Raboni MB Nogueira LR Tsuchiya GA Takahashi LA Pereira R Pasquini 2003 Respiratory tract viral infections in bone marrow transplant patients Transplantation 76 142 6 10.1097/01.TP.0000072012.26176.58
7. J Elizaga E Olavarria J Apperley J Goldman K Ward 2001 Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment Clin Infect Dis 32 413 8 10.1086/318498
8. E Sparrelid P Ljungman E Ekelof-Andstrom J Aschan O Ringden J Winiarski 1997 Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections Bone Marrow Transplant 19 905 8 10.1038/sj.bmt.1700752
9. S Chakrabarti KE Collingham K Holder S Oyaide D Pillay DW Milligan 2000 Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy Clin Infect Dis 31 1516 8 10.1086/317482
10. CH Wendt DJ Weisdorf MC Jordan HH Balfour Jr MI Hertz 1992 Parainfluenza virus respiratory infection after bone marrow transplantation N Engl J Med 326 921 6
11. VA Lewis R Champlin J Englund R Couch JM Goodrich K Rolston 1996 Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients Clin Infect Dis 23 1033 7
12. I Lee TD Barton 2007 Viral respiratory tract infections in transplant patients: epidemiology, recognition and management Drugs 67 1411 27 10.2165/00003495-200767100-00004
13. RE Champlin E Whimbey 2001 Community respiratory virus infections in bone marrow transplant recipients: the M. D. Anderson Cancer Center experience Biol Blood Marrow Transplant 7 8S 10S 10.1053/bbmt.2001.v7.pm11777103
14. BN Crooks CE Taylor AJ Turner HK Osman M Abinun TJ Flood 2000 Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit Bone Marrow Transplant 26 1097 102 10.1038/sj.bmt.1702656
15. PJ Gavin BZ Katz 2002 Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children Pediatrics 110 e9 10.1542/peds.110.1.e9
16. SN Markovic A Adlakha TF Smith RC Walker 1998 Respiratory syncytial virus pneumonitis-induced diffuse alveolar damage in an autologous bone marrow transplant recipient Mayo Clin Proc 73 153 6
17. WG Nichols T Gooley M Boeckh 2001 Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience Biol Blood Marrow Transplant 7 11S 5S 10.1053/bbmt.2001.v7.pm11777098
18. K Field MA Slavin JF Seymour 2002 Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia Eur J Haematol 69 54 7 10.1034/j.1600-0609.2002.02745.x
19. JJ Wright G O'Driscoll 2005 Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone J Heart Lung Transplant 24 343 6 10.1016/j.healun.2004.01.003
20. VH Tam SL Preston GL Drusano 2003 Comparative pharmacokinetic analysis by standard two-stage method versus nonparametric population modeling Pharmacotherapy 23 1545 9 10.1592/phco.23.15.1545.31969
21. SL Preston GL Drusano P Glue J Nash SK Gupta P McNamara 1999 Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology Antimicrob Agents Chemother 43 2451 6
22. JJ Lertora AB Rege JT Lacour N Ferencz WJ George RB VanDyke 1991 Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus Clin Pharmacol Ther 50 442 9
23. OL Laskin JA Longstreth CC Hart D Scavuzzo CM Kalman JD Connor 1987 Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome Clin Pharmacol Ther 41 546 55
24. SN Croup 1993 J Fam Pract 37 165 70
25. AM Luks MJ Neff 2007 Pneumocystis jiroveci pneumonia Respir Care 52 59 63
26. R Battikh F M'Sadek N Ben Abdelhafidh B Louzir J Labidi F Ajili 2007 Pneumocystis pneumonia in 3 non HIV patients Med Mal Infect 37 605 8 10.1016/j.medmal.2006.03.005
27. SA Bozzette FR Sattler J Chiu AW Wu D Gluckstein C Kemper 1990 A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group N Engl J Med 323 1451 7
28. VC Cheng BS Tang AK Wu 2004 Medical treatment of viral pneumonia including SARS in immunocompetent adult J Infect 49 262 73 10.1016/j.jinf.2004. 07.010
29. N Adhami Y Arabi A Raees A Al-Shimemeri M Ur-Rahman ZA Memish 2006 Effect of corticosteroids on adult varicella pneumonia: cohort study and literature review Respirology 11 437 41 10.1111/j.1440-1843.2006.00870.x